Filed: 2026-04-23 AccNo: 0001193125-26-171717 Size: 643 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
424B5 - NEKTAR THERAPEUTICS
Filed:
2026-04-20
AccNo:
0001193125-26-164201
Size:
540 KB
发布时间04/20 21:00 UTC
首次发现04/20 21:05 UTC
热度102.6
重要度38
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 546 字符
Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001193125-26-164201
Filing Date: 2026-04-20
Accepted: 2026-04-20 17:00:25
Documents: 3
NEKTAR THERAPEUTICS (Filer) CIK : 0000906709 (see all company filings) EIN. : 943134940 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B5 | Act: 33 | File No.: 333-291466 | Film No.: 26875815 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 424B5 | d138057d424b5.htm | 424B5
2 | GRAPHIC | g138057g02a02.jpg | GRAPHIC
3 | GRAPHIC | g138057g32t43.jpg | GRAPHIC
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇